InvestorsHub Logo
Followers 43
Posts 2488
Boards Moderated 0
Alias Born 10/19/2015

Re: None

Wednesday, 09/14/2022 11:55:33 AM

Wednesday, September 14, 2022 11:55:33 AM

Post# of 462246
This kept me up late last night and the more I think about it, the more sense it makes.

Anavex has a 4+ year runway's worth of cash, but does it really need that many years in the coffers? If there's a recession (looking more likely) and Anavex is dragged down with the general market, which it will be, why not use that cash for a stock repurchase or a one-time special cash dividend with a DRIP option?

If the drug works, we'll know within 18 months if not sooner making the 4 year runway somewhat moot. If the drug fails, it's unlikely most of us will stick around to see how A371 fares so who cares if they're able to run a P2B trial there?

The bet is on A273 working. If it does, the reduced float will only help create more demand for shares when word spreads if Anavex gets approval.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News